Ocugen stock jumped another 6% in premarket trading after soaring more than 18% yesterday amid heightened interest in the stock from retail traders on social media.
According to SwaggyStocks, Ocugen was the fifth most mentioned stock on Reddit's r/wallstreetbets.
Traders also circulated a recent release from the Australian Government mentioning recognition of Bharat Biotech's COVAXIN. NOTE: Ocugen is a partner on COVAXIN.
Ocugen's average session volume is 21.45 million over a 100-day period.
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases.
关注我们